HomeCGEM • NASDAQ
add
Cullinan Therapeutics Inc
Previous close
$23.17
Day range
$23.17 - $24.44
Year range
$7.64 - $30.19
Market cap
1.38B USD
Avg Volume
1.12M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 42.99M | -31.50% |
Net income | -37.15M | 35.91% |
Net profit margin | — | — |
Earnings per share | -0.86 | 39.44% |
EBITDA | -42.91M | 31.54% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 433.01M | 10.83% |
Total assets | 449.43M | -12.73% |
Total liabilities | 23.76M | -19.00% |
Total equity | 425.66M | — |
Shares outstanding | 57.63M | — |
Price to book | 2.35 | — |
Return on assets | -23.02% | — |
Return on capital | -24.25% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -37.15M | 35.91% |
Cash from operations | -38.25M | 25.00% |
Cash from investing | 12.96M | -14.67% |
Cash from financing | 1.08M | -39.35% |
Net change in cash | -24.21M | 28.86% |
Free cash flow | -24.25M | 22.60% |
About
Founded
2016
Website
Employees
85